49 related articles for article (PubMed ID: 38581025)
1. Prognostic role of
Luo XX; Li SZ; Wang L; Luo AL; Qiu H; Yuan XL
Heliyon; 2024 May; 10(10):e31403. PubMed ID: 38803848
[TBL] [Abstract][Full Text] [Related]
2. GGT5 facilitates migration and invasion through the induction of epithelial-mesenchymal transformation in gastric cancer.
Luo Z; Chen Y; Chen B; Zhao Z; Wu R; Ren J
BMC Med Genomics; 2024 Apr; 17(1):82. PubMed ID: 38581025
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L
J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925
[TBL] [Abstract][Full Text] [Related]
4. MiR-675 is frequently overexpressed in gastric cancer and enhances cell proliferation and invasion via targeting a potent anti-tumor gene PITX1.
Liu L; Tian YC; Mao G; Zhang YG; Han L
Cell Signal; 2019 Oct; 62():109352. PubMed ID: 31260797
[TBL] [Abstract][Full Text] [Related]
5. Block of Proliferation 1 Promotes Proliferation, Invasion and Epithelial Mesenchymal Transformation in Gastric Cancer.
He J; Chen Z; Xue Q; Shi W
Oxid Med Cell Longev; 2022; 2022():2946989. PubMed ID: 35222794
[TBL] [Abstract][Full Text] [Related]
6. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy and Immune Checkpoint Blockade for Gastric and Gastroesophageal Junction Adenocarcinoma.
Manji GA; Lee S; Del Portillo A; May M; Ana SS; Alouani E; Sender N; Negri T; Gautier K; Ge L; Fan W; Xie M; Sethi A; Schrope B; Tan AC; Park H; Oberstein PE; Shah MA; Raufi AG
JAMA Oncol; 2023 Dec; 9(12):1702-1707. PubMed ID: 37856106
[TBL] [Abstract][Full Text] [Related]
8. Early stage gastric adenocarcinoma: clinical and molecular landscapes.
Hirata Y; Noorani A; Song S; Wang L; Ajani JA
Nat Rev Clin Oncol; 2023 Jul; 20(7):453-469. PubMed ID: 37264184
[TBL] [Abstract][Full Text] [Related]
9. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention.
Thrift AP; Wenker TN; El-Serag HB
Nat Rev Clin Oncol; 2023 May; 20(5):338-349. PubMed ID: 36959359
[TBL] [Abstract][Full Text] [Related]
10. The HBV web: An insight into molecular interactomes between the hepatitis B virus and its host en route to hepatocellular carcinoma.
Kar A; Samanta A; Mukherjee S; Barik S; Biswas A
J Med Virol; 2023 Jan; 95(1):e28436. PubMed ID: 36573429
[TBL] [Abstract][Full Text] [Related]
11. Current developments in gastric cancer: from molecular profiling to treatment strategy.
Alsina M; Arrazubi V; Diez M; Tabernero J
Nat Rev Gastroenterol Hepatol; 2023 Mar; 20(3):155-170. PubMed ID: 36344677
[TBL] [Abstract][Full Text] [Related]
12. Identification of
Wang Y; Fang Y; Zhao F; Gu J; Lv X; Xu R; Zhang B; Fang Z; Li Y
Front Genet; 2022; 13():810292. PubMed ID: 35368661
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
